gabapentin has been researched along with Bone Neoplasms in 11 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A rat model of cancer-induced bone pain using the MRMT-1 cell line injected into the tibia was established to investigate the efficacy of acute (10, 30, 100 mg/kg) and chronic (30 mg/kg) systemic gabapentin on electrophysiological superficial dorsal horn neuronal responses to natural and noxious electrical stimuli, as well as on pain-related behavior." | 7.73 | Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain. ( Dickenson, AH; Donovan-Rodriguez, T; Urch, CE, 2005) |
| " Based on the need for new approaches in that field the effect of systemic administration of lacosamide (SPM 927, (R)-2-acetamido-N-benzyl-3-methoxypropionamide, previously referred to as harkoseride or ADD 234037), a member of a series of functionalized amino acids that were specifically synthesized as anticonvulsive drug candidates, was examined in rats in a tumor-induced bone cancer pain model and in a chemotherapy-induced neuropathic pain model." | 3.74 | Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain. ( Bain, SC; Beyreuther, BK; Brot, MD; Callizot, N; Feldman, R; Stöhr, T, 2007) |
| "A rat model of cancer-induced bone pain using the MRMT-1 cell line injected into the tibia was established to investigate the efficacy of acute (10, 30, 100 mg/kg) and chronic (30 mg/kg) systemic gabapentin on electrophysiological superficial dorsal horn neuronal responses to natural and noxious electrical stimuli, as well as on pain-related behavior." | 3.73 | Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain. ( Dickenson, AH; Donovan-Rodriguez, T; Urch, CE, 2005) |
| "This severe pain is mostly refractory to palliative analgesic treatment, and the latter was only detected by specific and sensitive outcomes." | 2.87 | Pain characterization and response to palliative care in dogs with naturally-occurring appendicular osteosarcoma: An open label clinical trial. ( Beauchamp, G; Blair, J; de Lorimier, LP; Lussier, B; Monteiro, BP; Moreau, M; Pelletier, JP; Troncy, E, 2018) |
| "Delirium is still one of the most common and distressing symptoms in palliative care patients." | 1.38 | Reversible delirium in an advanced cancer patient. ( Jagsch, C; Kierner, KA; Watzke, HH, 2012) |
| "Gabapentin, which has been suggested as an adjuvant analgesic for neuropathic pain introduced orally, rapidly and significantly alleviated his pain and we could subsequently dispense with ketamine and mexiletine." | 1.34 | [Gabapentin mitigates neuropathic pain in cancer patients--a case report]. ( Okada, M; Shinjo, T, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corona-Ramos, JN | 1 |
| Déciga-Campos, M | 1 |
| Romero-Piña, M | 1 |
| Medina, LA | 1 |
| Martínez-Racine, I | 1 |
| Jaramillo-Morales, OA | 1 |
| García-López, P | 1 |
| López-Muñoz, FJ | 1 |
| Wang, X | 1 |
| Yi, Y | 1 |
| Tang, D | 1 |
| Chen, Y | 1 |
| Jiang, Y | 1 |
| Peng, J | 1 |
| Xiao, J | 1 |
| Kendall, MC | 1 |
| Castro-Alves, LJ | 1 |
| Anghelescu, DL | 1 |
| Pankayatselvan, V | 1 |
| Nguyen, R | 1 |
| Ward, D | 1 |
| Wu, J | 1 |
| Wu, H | 1 |
| Edwards, DD | 1 |
| Furman, W | 1 |
| Monteiro, BP | 1 |
| de Lorimier, LP | 1 |
| Moreau, M | 1 |
| Beauchamp, G | 1 |
| Blair, J | 1 |
| Lussier, B | 1 |
| Pelletier, JP | 1 |
| Troncy, E | 1 |
| Caraceni, A | 1 |
| Zecca, E | 1 |
| Martini, C | 1 |
| Pigni, A | 1 |
| Bracchi, P | 1 |
| Menéndez, L | 1 |
| Hidalgo, A | 1 |
| Meana, A | 1 |
| Poras, H | 1 |
| Fournié-Zaluski, MC | 1 |
| Roques, BP | 1 |
| Baamonde, A | 1 |
| Kierner, KA | 1 |
| Jagsch, C | 1 |
| Watzke, HH | 1 |
| Donovan-Rodriguez, T | 1 |
| Dickenson, AH | 1 |
| Urch, CE | 1 |
| Beyreuther, BK | 1 |
| Callizot, N | 1 |
| Brot, MD | 1 |
| Feldman, R | 1 |
| Bain, SC | 1 |
| Stöhr, T | 1 |
| Okada, M | 1 |
| Shinjo, T | 1 |
2 trials available for gabapentin and Bone Neoplasms
| Article | Year |
|---|---|
Gabapentin as an Adjuvant Therapy for Prevention of Acute Phantom-Limb Pain in Pediatric Patients Undergoing Amputation for Malignant Bone Tumors: A Prospective Double-Blind Randomized Controlled Trial.
Topics: Adolescent; Amputation, Surgical; Analgesics; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Double- | 2018 |
Pain characterization and response to palliative care in dogs with naturally-occurring appendicular osteosarcoma: An open label clinical trial.
Topics: Amitriptyline; Analgesics; Animals; Bone Neoplasms; Central Nervous System Sensitization; Dog Diseas | 2018 |
9 other studies available for gabapentin and Bone Neoplasms
| Article | Year |
|---|---|
The Effect of Gabapentin and Tramadol in Cancer Pain Induced by Glioma Cell in Rat Femur.
Topics: Amines; Analgesics; Animals; Bone Neoplasms; Brain Neoplasms; Cancer Pain; Cell Line, Tumor; Cell Su | 2017 |
Gabapentin to Prevent Acute Phantom-Limb Pain in Pediatric Patients Undergoing Amputation.
Topics: Amputation, Surgical; Bone Neoplasms; Child; Double-Blind Method; Gabapentin; Humans; Phantom Limb; | 2018 |
Bisphosphonate Use in Pediatric Oncology for Pain Management.
Topics: Administration, Oral; Adolescent; Age Factors; Age of Onset; Analgesics, Opioid; Bone Neoplasms; Can | 2019 |
Gabapentin for breakthrough pain due to bone metastases.
Topics: Amines; Analgesics; Bone Neoplasms; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid | 2008 |
Inhibition of osteosarcoma-induced thermal hyperalgesia in mice by the orally active dual enkephalinase inhibitor PL37. Potentiation by gabapentin.
Topics: Administration, Oral; Amines; Analgesics; Animals; Bone Neoplasms; Cyclohexanecarboxylic Acids; Disu | 2008 |
Reversible delirium in an advanced cancer patient.
Topics: Amines; Analgesics; Analgesics, Opioid; Bone Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, No | 2012 |
Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain.
Topics: Amines; Analgesics; Animals; Behavior, Animal; Bone Neoplasms; Cell Line, Tumor; Cyclohexanecarboxyl | 2005 |
Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain.
Topics: Acetamides; Amines; Analgesics; Animals; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Cyclohex | 2007 |
[Gabapentin mitigates neuropathic pain in cancer patients--a case report].
Topics: Adenocarcinoma; Amines; Analgesics; Bone Neoplasms; Cyclohexanecarboxylic Acids; Gabapentin; gamma-A | 2007 |